year 11, Issue 42 (5-2012)                   J. Med. Plants 2012, 11(42): 16-42 | Back to browse issues page

XML Persian Abstract Print


1- Pharmacist Pharmacodynamics and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences
2- Pharmaceutical Research Center, Pharmacodynamics and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences
3- Pharmaceutical Research Center, Pharmacodynamics and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences , hosseinzadehh@mums.ac.ir
Abstract:   (9896 Views)
Nigella sativa is an annual plant in the family Ranunculaceae, native to southern Europe, north Africa and southwest Asia. N. sativa seeds contain fixed oils, proteins, alkaloids (such as nigellicine and nigellidine), quinones (such as thymoquinone), saponin and essential oil. In traditional medicine, it has been used for several diseases such as antihelmintic, amenorrhea, asthma, diabetes, cough, diuretic and lactagogue. Pharmacological and biological activities of N. sativa and its constituents such as thymoquinone have been shown to be antioxidant, anti-ischemia, antinociceptive and anti-inflammatory, anticonvulsant and antitussive.
Full-Text [PDF 922 kb]   (8326 Downloads)    
Type of Study: Research | Subject: Pharmacognosy & Pharmaceutics
Received: 2010/04/24 | Accepted: 2011/09/14 | Published: 2012/06/20

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.